Market

This Mumbai meditech company is set to become the first to list on BSE’s startup platform

Updated : September 03, 2019 09:01 PM IST

The Mumbai-based maker of therapeutic devices had opened its maiden IPO on August 26, 2019 at an issue size of 104,000 equity shares of face value Rs 10 each at Rs 130 a share.

Transpact received regulatory approvals to list on the BSE Start-up Platform on August 20, 2019.

Transpact Enterprises is due to become the first startup to list on the Bombay Stock Exchange’s (BSE) platform for such enterprises on September 5, 2019.

The Mumbai-based maker of therapeutic devices had opened its maiden IPO on August 26, 2019 at an issue size of 104,000 equity shares of face value Rs 10 each at Rs 130 a share.

The company will use the proceeds of the IPO to acquire an R&D facility and registered office, conduct further clinical studies for new disorders, redeem preferential shares and for working capital, it said in a statement.

Transpact received regulatory approvals to list on the BSE Start-up Platform on August 20, 2019. The IPO was fully subscribed on Day 3.

The company was incubated at the Society for Innovation and Entrepreneurship and Indian Institute of Technology, Bombay.

This Mumbai meditech company is set to become the first to list on BSE’s startup platform

You May Also Like

Expect real GDP to decline 1-2% YoY in 3QFY21: Report

All states choose option-1 to meet GST implementation shortfall

Rate-sensitive stocks rise after RBI policy announcement: Bank, realty indices up 1%

Trending on CNBC-TV18

recommended for you